Reply to comment on: “Advantages of bevacizumab for aggressive posterior retinopathy of prematurity” - Sidney A Schechet; Sarah Hilkert Rodriguez; Michael J Shapiro; Michael P Blair (Taiwan Journal of Ophthalmology, 2019)